BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1541707)

  • 1. Increased PIVKA-II concentrations in patients with cystic fibrosis.
    de Montalembert M; Lenoir G; Saint-Raymond A; Rey J; Lefrère JJ
    J Clin Pathol; 1992 Feb; 45(2):180-1. PubMed ID: 1541707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K and the management of patients with cystic fibrosis.
    Durie PR
    CMAJ; 1994 Oct; 151(7):933-6. PubMed ID: 7922929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K status in cystic fibrosis.
    Cornelissen EA; van Lieburg AF; Motohara K; van Oostrom CG
    Acta Paediatr; 1992 Sep; 81(9):658-61. PubMed ID: 1421902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIVKA-II concentrations in patients with cystic fibrosis.
    Cornelissen EA; van Lieburg AF; van Oostrom CG; Monnens L
    J Clin Pathol; 1992 Aug; 45(8):742. PubMed ID: 1401195
    [No Abstract]   [Full Text] [Related]  

  • 5. Exogenous and endogenous determinants of vitamin K status in cystic fibrosis.
    Krzyżanowska P; Pogorzelski A; Skorupa W; Moczko J; Grebowiec P; Walkowiak J
    Sci Rep; 2015 Jul; 5():12000. PubMed ID: 26160248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of vitamin K deficiency in CF--how much sophistication is useful?
    Mosler K; von Kries R; Vermeer C; Saupe J; Schmitz T; Schuster A
    J Cyst Fibros; 2003 Jun; 2(2):91-6. PubMed ID: 15463856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors.
    Shapiro AD; Jacobson LJ; Armon ME; Manco-Johnson MJ; Hulac P; Lane PA; Hathaway WE
    J Pediatr; 1986 Oct; 109(4):675-80. PubMed ID: 3761086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diagnostic value of protein induced by vitamin K absence or antagonist-II in non-infant patients with acquired deficiency of vitamin K-dependent coagulation factors].
    Wang J; Wu T; Ren C; Shen H; Chen H; Yu Z; Wang Z
    Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):104-7. PubMed ID: 24767160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vitamin K deficiency in cystic fibrosis: Effectiveness of a daily fat-soluble vitamin combination.
    Wilson DC; Rashid M; Durie PR; Tsang A; Kalnins D; Andrew M; Corey M; Shin J; Tullis E; Pencharz PB
    J Pediatr; 2001 Jun; 138(6):851-5. PubMed ID: 11391328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin and PIVKA-II levels in cord blood from newborn exposed to anticonvulsants during pregnancy.
    Howe AM; Oakes DJ; Woodman PD; Webster WS
    Epilepsia; 1999 Jul; 40(7):980-4. PubMed ID: 10403223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new mixed micellar preparation for oral vitamin K prophylaxis: randomised controlled comparison with an intramuscular formulation in breast fed infants.
    Greer FR; Marshall SP; Severson RR; Smith DA; Shearer MJ; Pace DG; Joubert PH
    Arch Dis Child; 1998 Oct; 79(4):300-5. PubMed ID: 9875038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIVKA-II correlates with INR but not protein C or protein S concentrations in cord blood among newborns.
    Teruya M; Soundar E; Hui SR; Eldin K; Adcock D; Teruya J
    J Neonatal Perinatal Med; 2016 May; 9(2):139-43. PubMed ID: 27197928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
    Strople J; Lovell G; Heubi J
    J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIVKA-II plasma levels as markers of subclinical vitamin K deficiency in term infants.
    Dituri F; Buonocore G; Pietravalle A; Naddeo F; Cortesi M; Pasqualetti P; Tataranno ML; Agostino R
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1660-3. PubMed ID: 22280352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of vitamin K deficiency and associated factors in non-supplemented cystic fibrosis patients.
    Krzyżanowska P; Drzymala-Czyż S; Rohovyk N; Bober L; Moczkco J; Rachel M; Walkowiak J
    Arch Argent Pediatr; 2018 Feb; 116(1):e19-e25. PubMed ID: 29333815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K-dependent coagulation parameters during the first six days of life: incidence of PIVKA II in newborns.
    Boos J; Pollmann H; Dominick HC
    Pediatr Hematol Oncol; 1989; 6(2):113-9. PubMed ID: 2702065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of vitamin K deficiency in cystic fibrosis.
    Rashid M; Durie P; Andrew M; Kalnins D; Shin J; Corey M; Tullis E; Pencharz PB
    Am J Clin Nutr; 1999 Sep; 70(3):378-82. PubMed ID: 10479200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suboptimal vitamin K status despite supplementation in children and young adults with cystic fibrosis.
    Dougherty KA; Schall JI; Stallings VA
    Am J Clin Nutr; 2010 Sep; 92(3):660-7. PubMed ID: 20554788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vitamin K deficiency in patients with CF despite supplementation].
    Krzyzanowska P; Lisowska A; Skorupa W; Pogorzelski A; Kamińska B; Cichy W; Popiel A; Walkowiak J
    Med Wieku Rozwoj; 2010; 14(1):68-72. PubMed ID: 20608431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K Status in Adherent and Non-Adherent Patients with Phenylketonuria: A Cross-Sectional Study.
    Mozrzymas R; Walkowiak D; Drzymała-Czyż S; Krzyżanowska-Jankowska P; Duś-Żuchowska M; Kałużny Ł; Walkowiak J
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.